Petyo G. Hadzhiyski

Sofia, Bulgaria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Increased prevalence of Helicobacter pylori and CagA seropositivity in Bulgarian children with type 1 diabetes mellitus.

Increased prevalence of Helicobacter pylori and CagA seropositivity in Bulgarian children with type 1 diabetes mellitus.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: July 13, 2026

Some Newer Antibiotics Active Against Helicobacter pylori and Anaerobic Bacteria and the Potential Benefits of Their Wider Availability in More Countries: A Narrative Review.

Some Newer Antibiotics Active Against Helicobacter pylori and Anaerobic Bacteria and the Potential Benefits of Their Wider Availability in More Countries: A Narrative Review.

Journal: Antibiotics (Basel, Switzerland)

Published: May 03, 2026

In vitro activity of eravacycline compared to other antibiotics commonly used for treatment of infections involving anaerobic bacteria: a review of the literature and our own data.

In vitro activity of eravacycline compared to other antibiotics commonly used for treatment of infections involving anaerobic bacteria: a review of the literature and our own data.

Journal: Diagnostic microbiology and infectious disease

Published: December 14, 2025

Delafloxacin and levofloxacin activities on Helicobacter pylori in Bulgaria over four years.

Delafloxacin and levofloxacin activities on Helicobacter pylori in Bulgaria over four years.

Journal: Diagnostic microbiology and infectious disease

Published: March 27, 2025

Oxygen tolerance in anaerobes as a virulence factor and a health-beneficial property.

Oxygen tolerance in anaerobes as a virulence factor and a health-beneficial property.

Journal: Anaerobe

Published: June 02, 2024

Clostridioides difficile resistance to antibiotics, including post-COVID-19 data.

Clostridioides difficile resistance to antibiotics, including post-COVID-19 data.

Journal: Expert review of clinical pharmacology

Published: August 29, 2023

Mixed (multiple-genotype) Helicobacter pylori infections in Bulgarian patients.

Mixed (multiple-genotype) Helicobacter pylori infections in Bulgarian patients.

Journal: Diagnostic microbiology and infectious disease

Published: June 20, 2023

Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern.

Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern.

Journal: Antibiotics (Basel, Switzerland)

Published: January 10, 2023

Anaerobes in specific infectious and noninfectious diseases: new developments.

Anaerobes in specific infectious and noninfectious diseases: new developments.

Journal: Anaerobe

Published: November 19, 2022

Anti-tumor necrosis factor therapy in Bulgarian pediatric patients with inflammatory bowel disease - an 8-year experience of a referral center.

Anti-tumor necrosis factor therapy in Bulgarian pediatric patients with inflammatory bowel disease - an 8-year experience of a referral center.

Journal: Folia medica

Published: March 25, 2022

Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.

Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.

Journal: Diagnostic microbiology and infectious disease

Published: January 23, 2022

Investigation of multidrug-resistant Helicobacter pylori in pediatric patients: A Bulgarian study and literature data.

Investigation of multidrug-resistant Helicobacter pylori in pediatric patients: A Bulgarian study and literature data.

Journal: Acta microbiologica et immunologica Hungarica

Published: December 12, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026